Mobile

FAST – A randomised, open-label, parallel, multicentre Phase IIIb Study to evaluate the Efficacy and Safety of Quetiapine IR titrared over 4 Days in Patients with Acute Psychosis (Rapid versus Convent...

Update Il y a 4 ans
Reference: EUCTR2006-006426-26

FAST – A randomised, open-label, parallel, multicentre Phase IIIb Study to evaluate the Efficacy and Safety of Quetiapine IR titrared over 4 Days in Patients with Acute Psychosis (Rapid versus Conventional Titration)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The main objective is to compare the efficacy of quetiapine IR in patients with acute schizophrenia, schizoaffective disorder, psychosis NOS or bipolar mania with psychotic symptoms, following rapid titration versus conventional titration, by assessment of Positive and PANSS-EC at Day 5 compared with baseline at Day 1.

Inclusion criteria

  • Patients requiring treatment, as judged by the Investigator, for an acute episode of schizophrenia, schizoaffective disorder, psychosis NOS or bipolar mania (according to DSM-IV criteria)

Links